SomaLogic

company

Number of Lead Investors

Number of Investors

SomaLogic is funded by 37 investors. iCarbonX and dRx Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
iCarbonX	Yes	Series Unknown
dRx Capital	Yes	Series A
ARK Investment Management	-	Post-IPO Equity
Casdin Capital	-	Post-IPO Equity
Corvex	-	Post-IPO Equity
Counterpoint Global	-	Post-IPO Equity
Farallon Capital Management	-	Post-IPO Equity
Illumina	-	Post-IPO Equity
Janus Henderson Investors	-	Post-IPO Equity
Novartis Pharma	-	Post-IPO Equity
Perceptive Advisors	-	Post-IPO Equity
SoftBank Capital	-	Post-IPO Equity
T. Rowe Price	-	Post-IPO Equity
Amgen	-	Series A
Boston Millennia Partners	-	Series A
Intermountain Ventures	-	Series A
Logos Capital	-	Series A
Millennium Management	-	Series A
NEC Solution Innovators	-	Series A
Novartis	-	Series A
Redmile Group	-	Series A
Revelation Partners	-	Series A
Ziff Capital Partners	-	Series A
Blue Water Life Science Fund	-	Series A
Fiscus Ventures	-	Series A
Foresite Capital	-	Series A
Madryn Asset Management	-	Series A
Monashee Investment Management	-	Series A
Mossrock Capital	-	Series A
Reimagined Ventures	-	Series A
Soleus Capital	-	Series A
Nan Fung Life Sciences	-	Series Unknown
Otsuka Pharmaceutical	-	Series Unknown
ProQuest Investments	-	Series Unknown
Quest Diagnostics	-	Series Unknown
Visium Healthcare Partners	-	Series Unknown
Bill & Melinda Gates Foundation	-	Grant